Infratil Reports Surge in CDC Investment Valuation

Infratil Limited (IFUUF) has released an update.

Infratil Limited has reported a significant A$287 million increase in the valuation of its 48.17% investment in CDC as of September 30, 2024, with the investment now valued between A$4,386 million and A$5,248 million. This uptick is attributed to strong customer interest and expansion in CDC’s development activities, particularly in Melbourne and Auckland, leading to a forecasted increase in build capacity by 409MW by FY2034. Despite rising asset-specific risk premiums contributing to a higher cost of equity, CDC plans to leverage various debt markets for the funding required for its growing development pipeline.

For further insights into IFUUF stock, check out TipRanks’ Stock Analysis page.